Cannabis
SpeakEasy Announces Health Canada has Granted an Amendment to its Sales Licence to Sell Dried Cannabis Flower and Products
SpeakEasy Cannabis Club Ltd. (CSE: EASY) (Frankfurt: 39H) (the “Company” or “SpeakEasy“) a holder of a federal licence to cultivate, process and sell cannabis under the Cannabis Act announces it has received its licence to sell flower into the recreational market and directly to medical patients.
Health Canada has amended SpeakEasy’s current production and processing licence to allow sales of its flower and pre-rolls into provincial dispensaries and directly to medical patients opening up the path to higher margins by eliminating the necessity to sell to other licence holders. This allows SpeakEasy to be a direct supplier of finished packaged products and not just bulk unpackaged cannabis.
Founder, Marc Geen states, “Another huge milestone has been achieved. This step represents the transition from a farm gate wholesaler to a manufacturer of finished products for retail sale. This has been the long-term plan from the very inception of this company more than 7 years ago and is the culmination of a colossal effort to be able to offer our products directly to consumers.”
Increased margin business model
SpeakEasy’s vision has always been focused on a business to consumer model, that is now becoming a reality. This amendment is expected to increase our margins, protect us from market fluctuations with respect to raw materials and allow us to create demand for our product by reaching consumers directly. Working with other licensed producers to supply raw flower, co- branding products, custom growing and processing is in our best interest and will continue in the future. SpeakEasy has been very fortunate to have found likeminded operators within the industry and forged strong ties that it will work with to continue existing contracts and develop new sales opportunities.
Building brand equity for the future
With the receipt of our license to permit sales of cannabis flower, we can now focus on brand awareness and sales to customers. “B.C. Bud” has a mystique all by itself and those who can capitalize on that by producing flower worthy of the “B.C. Bud” reputation will reap the rewards of global recognition. SpeakEasy represents the skill and craftsmanship found in legacy market growers here in B.C. and will enter the market giving customers what they are looking for. SpeakEasy brands that accentuate everything “BC Bud” represents have been created and will soon be released into the market now that we have our amended sales licence.
Founder, Marc Geen states, “Like an iceberg, 90 percent of SpeakEasy, up to this point, has been below the surface. So much activity and work goes unseen until a point is reached where a thousand small things all come together, this is one of those moments. Achieving the amended sales licence requires an immense amount of work and represents a radical change in direction for the Company. Sales and marketing can now be directed towards our consumers, we can get our product out there that speaks for itself. We have waited a long time to be on this stage and everyone here is excited about the opportunity.”
Geen further states, “The importance of this achievement cannot be overstated, a huge thank you to our dedicated staff, without them we could not achieve all we have. The team at SpeakEasy has been more committed and more passionate over the last two years than any company could ask for.”
The Company also plans to grant up to 1,030,000 incentive stock options to certain of its directors, officers, employees and consultants. Such grant to be made in accordance with applicable securities laws and the policies of the Canadian Securities Exchange.
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis2 weeks ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer2 weeks ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE1 day ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET